In addition to identifying differentially expressed genes, we sought to uncover transcription factors that might regulate the differentially expressed genes specifically in BCR-ABL-independent resistant CML cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.